Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2)

  • Auteurs / Authors: Beau-Faller M, Texier M, Blons H, Richard N, Escande F, Melaabi S, Lizard S, De Fraipont F, Longchampt E, Morin F, Zalcman G, Pignon JP, Cadranel J
  • Journal / Conference: Clinical Lung Cancer
  • Année / Year: 2018
  • PMID: 30679079
  • Lien vers la publication: https://www.ncbi.nlm.nih.gov/pubmed/30679079
  • PDF: ERMETIC.CLC.02.2019pdf.pdf